News | March 31, 2026
Kenvue unleashes science-driven skincare offensive at American Academy of Dermatology meet
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The new assay consolidates screening for four major viral threats into a single workflow
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
Glenmark's Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg is the authorized generic to Savella Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg
Subscribe To Our Newsletter & Stay Updated
